BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37261487)

  • 1. Effect of a protein kinase B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization.
    Wang X; Wang P
    Wien Klin Wochenschr; 2024 Mar; 136(5-6):154-162. PubMed ID: 37261487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
    Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
    Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism.
    Su W; Li Z; Li F; Chen X; Wan Q; Liang D
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):783-8. PubMed ID: 23249709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
    Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
    J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic effects of catalpol on rat corneal neovascularization.
    Han Y; Shen M; Tang LY; Tan G; Yang QC; Ye L; Ye LH; Jiang N; Gao GP; Shao Y
    Mol Med Rep; 2018 Feb; 17(2):2187-2194. PubMed ID: 29207076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSCs inhibits the angiogenesis of HUVECs through the miR-211/Prox1 pathway.
    Pan J; Wang X; Li D; Li J; Jiang Z
    J Biochem; 2019 Jul; 166(1):107-113. PubMed ID: 31143937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma
    Chen YF; Wu S; Li X; Chen M; Liao HF
    Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo.
    Ge H; Tian P; Guan L; Yin X; Liu H; Xiao N; Xiong Y; Luo X; Sun Y; Qi D; Ni S; Liu P
    Exp Eye Res; 2013 Jul; 112():10-20. PubMed ID: 23562678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
    Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
    Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.
    Li Z; Li J; Zhu L; Zhang Y; Zhang J; Yao L; Liang D; Wang L
    Int J Nanomedicine; 2016; 11():6135-6148. PubMed ID: 27920521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
    Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
    Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p/VEGFA.
    Liu S; Gao J; Chen J
    Microvasc Res; 2021 Nov; 138():104233. PubMed ID: 34411571
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.
    Lu Y; Zheng Y; Ai J; Xu X
    Discov Med; 2016 May; 21(117):349-61. PubMed ID: 27355331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
    Sun Y; Su L; Wang Z; Xu Y; Xu X
    BMC Cell Biol; 2013 Feb; 14():8. PubMed ID: 23433118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DZ2002 alleviates corneal angiogenesis and inflammation in rodent models of dry eye disease via regulating STAT3-PI3K-Akt-NF-κB pathway.
    Wu CM; Mao JW; Zhu JZ; Xie CC; Yao JY; Yang XQ; Xiang M; He YF; Tong X; Litifu D; Xiong XY; Cheng MN; Zhu FH; He SJ; Lin ZM; Zuo JP
    Acta Pharmacol Sin; 2024 Jan; 45(1):166-179. PubMed ID: 37605050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats.
    Li Z; Yao L; Li J; Zhang W; Wu X; Liu Y; Lin M; Su W; Li Y; Liang D
    Int J Nanomedicine; 2012; 7():1163-73. PubMed ID: 22419865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization.
    Lee JE; Kim KL; Kim D; Yeo Y; Han H; Kim MG; Kim SH; Kim H; Jeong JH; Suh W
    Int J Nanomedicine; 2017; 12():4813-4822. PubMed ID: 28740387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin regulates corneal neovascularization through inhibition of YAP protein activation.
    Lin L; Zheng Y; Li Q; Sun Y; Huang Y; Liang L; Xu L; Zhao YE
    Exp Eye Res; 2024 Jan; 238():109747. PubMed ID: 38072353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3-mediated m
    Wang W; Ye W; Chen S; Tang Y; Chen D; Lu Y; Wu Z; Huang Z; Ge Y
    Cell Signal; 2023 Sep; 109():110784. PubMed ID: 37356601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.